| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10044552 | HBV | ENSG00000169083.18 | protein_coding | AR | Yes | No | 367 | A0A087WUX9 P10275 |
| TVIS10052789 | HBV | ENSG00000169083.18 | protein_coding | AR | Yes | No | 367 | A0A087WUX9 P10275 |
| TVIS30073184 | HIV | ENSG00000169083.18 | protein_coding | AR | Yes | No | 367 | A0A087WUX9 P10275 |
| TVIS44024288 | HTLV-1 | ENSG00000169083.18 | protein_coding | AR | Yes | No | 367 | A0A087WUX9 P10275 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | AR |
|---|---|
| DrugBank ID | DB00957 |
| Drug Name | Norgestimate |
| Target ID | BE0000132 |
| UniProt ID | P10275 |
| Regulation Type | partial agonist |
| PubMed IDs | 15625768 |
| Citations | Prifti S, Lelle I, Strowitzki T, Rabe T: Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells. Gynecol Endocrinol. 2004 Jul;19(1):18-21. |
| Groups | Approved; Investigational |
| Direct Classification | Steroid esters |
| SMILES | [H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=N/O |
| Pathways | |
| PharmGKB | PA164744346 |
| ChEMBL | CHEMBL1200934 |
